Gain Therapeutics: Funding, Investors & Team (Oct 2026)
Gain Therapeutics is a company that creates pharmacological chaperone drugs for rare metabolic disorders. Their drugs use Minoryx Direct Enzyme Therapy to discover new adjuvants that can help stabilize misfolding mutations and restore enzyme activity in patients. They focus on developing innovative drugs for rare pediatric genetic disorders and CNS diseases with significant medical needs. The company was founded in 2017 and is based in Bethesda, MD, USA.
Gain Therapeutics has raised $7.0M across 1 funding round on record, the most recent an undisclosed round of $7.0M announced in Jul 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gain Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2025.
Gain Therapeutics Funding Rounds
Gain Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Gain Therapeutics Funding Compared to Other Biotechnology Startups
Gain Therapeutics' latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gain Therapeutics in Biotechnology and Bethesda
Companies Similar to Gain Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Gain Therapeutics Funding FAQs
What does Gain Therapeutics do?
Gain Therapeutics is a company that creates pharmacological chaperone drugs for rare metabolic disorders. Their drugs use Minoryx Direct Enzyme Therapy to discover new adjuvants that can help stabilize misfolding mutations and restore enzyme activity in patients. They focus on developing innovative drugs for rare pediatric genetic disorders and CNS diseases with significant medical needs. The company was founded in 2017 and is based in Bethesda, MD, USA.
How much funding has Gain Therapeutics raised?
Gain Therapeutics has raised $7.0M across 1 round on record. The most recent is an undisclosed round of $7.0M announced in Jul 2025.
When did Gain Therapeutics last raise funding?
Gain Therapeutics' most recent funding round on record is an undisclosed round of $7.0M, announced in Jul 2025.
Who founded Gain Therapeutics?
FundedIQ lists Lorenzo Leoni (Founder) at Gain Therapeutics.
Where is Gain Therapeutics headquartered?
Gain Therapeutics is based in Bethesda, Maryland, United States.
How many employees does Gain Therapeutics have?
Gain Therapeutics is in the 11-50 employee band.
How does Gain Therapeutics' funding compare to other Biotechnology startups?
Gain Therapeutics' latest round of $7.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Gain Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gain Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.